Aamir (Hrsg.) Ahmad
Breast Cancer Metastasis and Drug Resistance
Challenges and Progress
Ebook (PDF Format)
Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic tar…
Mehr
Beschreibung
Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.
CHF 165.50
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-3-030-20301-6
- EAN: 9783030203016
- Produktnummer: 32475735
- Verlag: Springer
- Sprache: Englisch
- Erscheinungsjahr: 2019
- Plattform: PDF
- Masse: 9'610 KB
- Auflage: 2nd ed. 2019
Über den Autor
Aamir Ahmad, PhD, is Assistant Professor of Oncologic Sciences at University of South Alabama's Mitchell Cancer Institute, Mobile, AL, USA. He received his academic degrees from AMU, Aligarh, India and completed post-doctoral training at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. His research interests include understanding the mechanisms of cancer drug resistance and metastasis in different cancers, with emphasis on the role of microRNAs, non-coding RNAs, epigenetics, exosomes, cancer stem cells and a personalized approach. He has authored 160 scientific research / review articles, edited/co-edited 8 books and serves as Expert Reviewer for scientific proposals submitted to 8 different funding agencies in Europe, Asia and Africa. He is the Founding Editor-in-Chief of the journal Non-coding RNA Research, Section Editor for the journal Scientific Reports, and is Section Editor for the journal PLoS ONE. He is also the Editor-in-Chief of the Elsevier series 'Cancer Metastasis'.
22 weitere Werke von Aamir (Hrsg.) Ahmad:
Challenges and Progress
Ebook (EPUB Format)
CHF 212.00
Challenges and Progress
Ebook (PDF Format)
CHF 212.50
Challenges and Progress
Ebook (PDF Format)
CHF 259.50
Challenges and Progress
Ebook (PDF Format)
CHF 177.00
Challenges and Progress
Ebook (PDF Format)
CHF 110.50
Challenges and Progress
Ebook (PDF Format)
CHF 212.00
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.